Litcius/Paper detail

Novel PI3K/Akt/mTOR pathway inhibitors plus radiotherapy: Strategy for non-small cell lung cancer with mutant RAS gene

Kai Chen, Zhongjun Shang, Ai-lin Dai, Peiling Dai

2020Life Sciences33 citationsDOI

Topics & Concepts

PI3K/AKT/mTOR pathwayLung cancerRadiation therapyMutantCancer researchProtein kinase BMedicineOncologyCancerInternal medicineBiologyGeneSignal transductionGeneticsPI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and MutationsCancer Mechanisms and Therapy
Novel PI3K/Akt/mTOR pathway inhibitors plus radiotherapy: Strategy for non-small cell lung cancer with mutant RAS gene | Litcius